Australia's largest stock trading and investment forum Australia's #1 stock forum

PAL

Click for more information

0.00%

29.5¢ palla pharma limited

Ann: Palla Pharma Investor Presentation - FY19 Results & Outlook, page-5

First 5 Last

Share
Profile

Follow
Alee26

2,349 Posts.

262

29/02/20

03:51

Post #: 43229215
Share

Originally posted by WestNorth: ↑

I was always a big PAL advocate but recently that is changing. It seems that the acquisition of the Norwegian business has maybe allowed the muddying of the financials on how well their Australian arm of the business is performing.

I was looking through some of their historic presentations and they quoted a NRM efficiency increase back in 2016 to 91%. This year they have quoted a NRM efficiency increase of another 4% but they did not state what efficiency they are actually achieving. Surely prior to this year they would have made some further efficiency improvements on their 2016 achievement of 91%. So on top of their efficiency increase this year would it be safe to say they are achieving 96 or 97%? For people who have more of an industry insight does this seems achievable??

Expand

PAL Price at posting: 80.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Update: Index pulls back from record highs | October 16, 2024

KAU

Kaiser Reef reports new A1 untapped gold zone – flags move past 'remnant mining'

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

There are more pages in this discussion • 17 more messages in this thread...

First 5 Last

Add PAL (ASX) to my watchlist